Navigation Links
Nventa Announces Positive Interim Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial
Date:3/26/2008

tion. Such factors include, among others, the possibility that immunology responses may not be a predictor of clinical benefit; that immunological findings in our first two cohorts may not be consistent with findings from our third and fourth cohorts and future clinical studies; that safety and tolerability findings in our first three cohorts may not be consistent with findings from our fourth cohort and future clinical studies; that results from future clinical trials will not be consistent with our expectations; that we will not be able to recruit patients for our planned trials in a timely manner; our need for capital; risks associated with requirements for approvals by government agencies such as the FDA before products can be tested in clinical trials; the possibility that such government agency approvals will not be obtained in a timely manner or at all or will be conditioned in a manner that would impair our ability to advance development; risks associated with the requirement that a drug be found safe and effective after extensive clinical trials; our dependence on suppliers, collaborative partners and other third parties and the prospects and timing for obtaining clinical supply materials; our ability to attract and retain key personnel; and other factors as described in detail in our filings with the Canadian securities regulatory authorities at http://www.sedar.com.

Assumptions underlying our expectations regarding forward-looking statements or information contained in this press release include, among others, that immunology responses are a predictor of clinical benefit; that immunological findings in our first two cohorts will be consistent with findings from our third and fourth cohorts and future clinical studies; that safety and tolerability findings in our first two cohorts will be consistent with findings from our third and fourth cohorts and future clinical studies; that results from future c
'/>"/>

SOURCE Nventa Biopharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
2. Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial
3. Anacor Pharmaceuticals Announces Positive Results from Phase 2a Clinical Trial of AN2728 in Psoriasis Patients
4. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
5. IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study
6. Valor Medical Announces First Human Implant of Neucrylate AN(TM) for Treatment of Cerebral Aneurysm
7. Medicare Announces Expanded Coverage for Anticoagulation Patients, Opening the Door for More Patients to Test PT/INR at Home
8. Medicare Announces Expanded Coverage for Warfarin Patients Monitoring Clotting Time at Home
9. FluoroPharma Announces Commencement of Phase I Clinical Trial for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
10. Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen(R) Technology at Lower Doses
11. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014 The Leukemia & Lymphoma ... to advance an experimental cancer vaccine to treat ... stage of myeloma. The partnership is ... LLS forges collaborations with biotechnology companies to help ... OncoPep is developing a vaccine, PVX-410, designed to ...
(Date:8/28/2014)... Calif. , Aug. 28, 2014  STAAR Surgical Company ... marketer of implantable lenses and delivery systems for the eye, ... Health Care Conference at the New York Palace Hotel on ... Barry Caldwell , President and CEO will offer ... results, and operational developments and be joined by Steve ...
(Date:8/27/2014)... Aug. 28, 2014 China Nepstar Chain ... the "Company"), a leading retail drugstore chain in ... stores, today announced its unaudited financial results for ... Financial HighlightsFor the quarter ended June 30, 2014: ... million) compared to RMB638.8 million in the second ...
Breaking Medicine Technology:The Leukemia & Lymphoma Society Provides Equity Financing to OncoPep to Support Clinical Trial for Myeloma Vaccine 2STAAR Surgical To Present At The Baird 2014 Health Care Conference 2China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 11
... goBalto , developer of new generation web-based clinical research solutions, ... Tufts Center for the Study of Drug Development ... there is virtually no industry data available on the typical ... that this process takes. Tufts CSDD, an independent, ...
... 2011 Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased ... growth in the multi-billion dollar endoscopic market.  Solos Endoscopy ... Clinics, Healthcare Centers, Medical Centers and Surgery Centers across ... instrument internationally upon receiving the CE Mark. ...
Cached Medicine Technology:goBalto Sponsors Tufts CSDD Study to Benchmark the Clinical Trial Initiation Process 2Solos Endoscopy Poised for Tremendous Growth in Multi-Billion Dollar Endoscopic Market 2
(Date:8/28/2014)... Clarity PSO , an operating division of ... Patient Safety Organization (PSO) for another three-year period under ... Quality (AHRQ). Clarity PSO will continue to provide valuable ... true intentions of the Patient Safety and Quality Improvement ... eager to continue our journey as a PSO and ...
(Date:8/28/2014)... San Franisco, CA (PRWEB) August 28, 2014 ... emerging marijuana business sector recently launched a “Video” ... relevant news and general information on various cannabis ... section, individuals can find an assortment of news ... marijuana-related issues and announcements. A portion of the ...
(Date:8/28/2014)... PreDiabetes Centers, the nation’s top provider of ... to help clients and online readers send out summer ... Han Ashley developed variations of Roasted Veggie Pizza ... The PreDiabetes Centers Roasted Veggie Pizza recipe is made ... features a cheese substitute–ideal for people who are lactose ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 Vitals, a recognized ... Dr. Sabrina Fabi of Cosmetic Laser Dermatology one of their ... of thousands of patients to share their doctor experiences and ... manner, face time, and follow-ups. The Vitals Top 10 Doctor ... Dr. Fabi was ranked one of the highest by patients. ...
(Date:8/28/2014)... 28, 2014 It is not uncommon for ... unsuccessful dieting attempts. Many face ridicule and judgment and find ... thoughts and feelings, wondering why they keep gaining weight and ... solace in comfort foods, eating more and gaining more, leaving ... , Diet Doc has helped thousands safely, successfully and ...
Breaking Medicine News(10 mins):Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 2Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 3Health News:Emerging Cannabis Industry Website GreenRushReview.com Adds a Featured Video Section to Cover Marijuana Business Sector News 2Health News:Emerging Cannabis Industry Website GreenRushReview.com Adds a Featured Video Section to Cover Marijuana Business Sector News 3Health News:PreDiabetes Centers Concierge Chef Creates Tasty Grilled Veggie Pizza Recipes for Labor Day Party Menu 2Health News:PreDiabetes Centers Concierge Chef Creates Tasty Grilled Veggie Pizza Recipes for Labor Day Party Menu 3Health News:Dr. Sabrina Fabi of Cosmetic Laser Dermatology Recognized as Vitals Top 10 Doctor 2Health News:Diet Doc’s Medical Weight Loss Programs Announce New Help for Patients Who Want to Overcome Depression Caused by Excess Weight 2Health News:Diet Doc’s Medical Weight Loss Programs Announce New Help for Patients Who Want to Overcome Depression Caused by Excess Weight 3
... Offers Hope to Millions of Couples Seeking a Better Sex,Life, ... relieved by the,preliminary results of a new study that demonstrates ... lives. The exercises take,just 5 minutes a day but the ... who followed the simple PelvicToner exercise,programme reported an improved sex ...
... to farms, particularly to barns and farm milk, while ... to a group of German researchers, who will present ... Conference in Toronto on Wednesday, May 21., In a ... 59 non-farming mothers, the researchers believe they have proved ...
... their Prescription History, WALNUT CREEK, Calif., May ... ) announced today a new collaboration with,Google Health ... between,patients and providers. Working with Google, Longs will ... customers with the ability to import their,prescription information ...
... 18, 2008 TAP Pharmaceutical Products Inc. today reported ... new drug TAK-390MR, the first proton pump inhibitor (PPI) ... patients with erosive esophagitis (EE) and in maintenance of ... Disease Week (DDW) annual meeting in San Diego. , ...
... over T-cell counts for monitoring HIV treatment , ... can help identify those whose treatment will succeed or ... from pharmacy records, works at least as well as ... the immune system, according to research published in PLoS ...
... initiation and progression of prostate cancer have eluded ... researchers have identified a specific gene expression profile ... for future treatments. The findings, published in BioMed ... genes that are differentially expressed in certain prostate ...
Cached Medicine News:Health News:Is Female Sexual Dysfunction a Myth? 2Health News:Farm moms may help children beat allergies 2Health News:Longs Drugs Partners With Google on the Launch of Google Health 2Health News:TAK-390MR Phase 3 data presented at Digestive Disease Week 2Health News:TAK-390MR Phase 3 data presented at Digestive Disease Week 3Health News:TAK-390MR Phase 3 data presented at Digestive Disease Week 4Health News:Monitoring whether patients take medicines can help anticipate HIV treatment failure in Africa 2Health News:Monitoring whether patients take medicines can help anticipate HIV treatment failure in Africa 3Health News:Monitoring whether patients take medicines can help anticipate HIV treatment failure in Africa 4Health News:Monitoring whether patients take medicines can help anticipate HIV treatment failure in Africa 5Health News:Mapping of prostate cancer genes opens the door to new treatments 2
... Series refrigerators from Taylor-Wharton are uniquely designed ... convenient box-type storage racks and the lower ... storage. The RackSystems are available in four ... from 750 x 2ml vials to 4800 ...
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
... with concave seats and standard-sized backrests ... like seats, backrests, armrests, and casters ... recommended for the following environments: industry, ... health care and office. • With ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTP/1Q-PAL chairs are recommended for ... clean room, static control, health care ...
Medicine Products: